INmune Bio, Inc. (INMB)
1.22
-0.02
(-1.61%)
USD |
NASDAQ |
Jun 09, 16:00
1.29
+0.07
(+5.74%)
After-Hours: 05:19
INmune Bio Accounts Payable (Quarterly) : 4.684M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Sangamo Therapeutics, Inc. | 19.31M |
| Arrowhead Pharmaceuticals, Inc. | 30.75M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sarepta Therapeutics, Inc. | 70.38M |
| Anixa Biosciences, Inc. | 0.148M |